Market Overview

Aegis Capital Maintains Buy on Ironwood Pharmaceuticals, Inc., Raises PT to $19.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for IRWD

DateFirmActionFromTo
Jan 2016Mizuho SecuritiesInitiates Coverage onBuy
Dec 2015BTIG ResearchInitiates Coverage onBuy
May 2015Leerink SwannMaintainsMarket Perform

View More Analyst Ratings for IRWD
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (IRWD)

Get Benzinga's Newsletters